| Name | Title | Contact Details |
|---|
Watching your child struggle is hard. FSGC offers professional child counseling in Topeka to help them overcome their unique struggles.
Prejuvenation Aesthetics is a med spa in Ashburn, VA that specializes in preventative cosmetic treatments to enhance natural facial features and boost confidence.
HonorHealth is both a name and call to action. HonorHealth emphasizes the historic trustworthiness and integrity of our organization`s brand. It demonstrates our respect and dedication to delivering the highest quality care in a personal and easy manner. We are committed to providing the right care at the right time at the right place. We continue to engage our communities in wellness. We make it easier than ever for you to get the personalized care you need in a way that works for you. With more than 3,000 expert physicians, 10,000 dedicated employees, and 3,000 caring volunteers, HonorHealth continues to strengthen our communities, making sure that everyone has access to quality healthcare.
Frontline Dental Implant Specialists (FDIS) is a dental implant partnership network that brings together top dental implant specialists with over 150+ years of combined experience.
Discovery Laboratories, Inc. is a specialty biotechnology company focused on advancing a new standard in respiratory critical care. Discovery Labs` technology platform includes its novel proprietary KL4 surfactant, a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant, and its proprietary drug delivery technologies being developed to enable efficient delivery of aerosolized KL4 surfactant and other inhaled therapies. Discovery Labs` strategy is initially focused on neonatology and improving the management of respiratory distress syndrome (RDS) in premature infants. Discovery Labs believes that its RDS product portfolio has the potential to become the new standard of care for RDS and, over time, enable the treatment of a significantly greater number of premature infants who could benefit from surfactant therapy that are currently not being treated. In many pulmonary diseases, including RDS, acute lung injury (ALI), and other respiratory conditions, surfactant is either deficient or may fail to function properly. Our precision-engineered, peptide-containing KL4 surfactant has been designed to mimic the essential function of human pulmonary surfactant and may have the potential to address conditions such as these. We are developing our proprietary delivery technologies to one day enable efficient, targeted upper-respiratory or alveolar delivery of our KL4 surfactant in aerosolized form to allow for a gentler, less invasive delivery approach. These same delivery systems may also potentially be used to deliver a variety of additional aerosolized medicines safely and in a simplified way compared with the current standard of care.